Back to results

National Institutes of Health

Manufacturer

Headquarters

United States of America

Products & Services

2-Cyano-3,12-dioxoleana-1,9(11)-dien-28-oic acid (CD)

2-cyano-3, 12-dioxoleana-1, 9(11)-dien-28-oic acid (cddo)

3-O-LAUROYL-L-CARNITINE HYDROCHLORIDE (LLC) PRECLINICAL AND CLINICAL DATA

4-Nitroestrone 3-Methyl Ether

Bevacizumab Rituximab

Characterization of Aedes albopictus (C6/36) mosquito

Characterization of Aedes albopictus (C6/36) mosquito cell line

Cocaine Hydrochloride

Cocaine Hydrochloride Injectables

Cooperative Study Groups of Clinical Studies Panel

Daraprim (pyrimethamine)

Dimethyl Sulfoxide

Don (norleucine, 6-diazo-5-oxo-, l)

Drug Development Program

Elliott's B Solution

Gonadorelin

Gonadotropin Releasing Hormone (GnRH)

Humanized Mik-Beta-1 Monoclonal Antibody

Interleukin 2

Listing Div Biologics Notices (IND's)

Lymphilized Product of Aminopterin (NSC 739) 50mg

Marijuana (Product Code 1000)

Methamphetamine Hydrochloride

Methamphetamine hydrochloride injectable 10mg/1ml 5ml ampoules

NSC321803

Paludrine

PC-4 (Silicone Phthalocyanine)

Pentamidine Isethionate

Proguanil

Pseudomonas exotoxin (recombinant, NLYSPE38) conjugated murine MAB (B3) to B3 antigen and rituximab (chimeric MOAB (C2B8) (IDEC) to CD20)

Pyrimethamine

Pyroxamide CMC and Preclinical Pharmacology and Toxicology

Pyroxamide CMC and Preclinical Pharmacology and Toxicology Data

Recombinant Human Interleukin-15 (RHIL-15)

Sangivamycin HCL (NSC 143648) as prepared by the Frederick Cancer Res

Sangivamycin Hydrochloride

(S)-(+)-Methamphetamine Hydrochloride

Statement of Personnel Facilities and Controls for Processing

Statement of Personnel Facilities and Controls for Processing a New Drug

Tetrahydrocannabinol

Thymidine

Thymidine NSC21548

Uridine